Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Cerilliant
Fuji
Chinese Patent Office
Farmers Insurance
Covington
Chubb
McKinsey
Moodys
QuintilesIMS

Generated: August 20, 2017

DrugPatentWatch Database Preview

DULOXETINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Duloxetine Hydrochloride, and when can generic versions of Duloxetine Hydrochloride launch?

Duloxetine Hydrochloride is a drug marketed by Ajanta Pharma Ltd, Macleods Pharms Ltd, Dr Reddys Labs Ltd, Zydus Pharms Usa Inc, Inventia Hlthcare, Zydus Hlthcare, Hetero Labs Ltd Iii, Apotex Inc, Sun Pharma Global, Alembic Pharms Ltd, Prinston Inc, Torrent Pharms Ltd, Actavis Elizabeth, Aurobindo Pharma Ltd, Anchen Pharms, Teva Pharms Usa, Breckenridge Pharm, Lupin Ltd, and Alkem Labs Ltd. and is included in nineteen NDAs.

The generic ingredient in DULOXETINE HYDROCHLORIDE is duloxetine hydrochloride. There are forty-one drug master file entries for this compound. Fifty-six suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the duloxetine hydrochloride profile page.

Summary for Tradename: DULOXETINE HYDROCHLORIDE

Patents:0
Applicants:19
NDAs:19
Suppliers / Packagers: see list46
Bulk Api Vendors: see list55
Clinical Trials: see list2,480
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DULOXETINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: DULOXETINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
DULOXETINE HYDROCHLORIDE
duloxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL090778-002Dec 11, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Prinston Inc
DULOXETINE HYDROCHLORIDE
duloxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL206653-002May 18, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
DULOXETINE HYDROCHLORIDE
duloxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL203088-001Jun 11, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Anchen Pharms
DULOXETINE HYDROCHLORIDE
duloxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL090780-003Oct 28, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
DULOXETINE HYDROCHLORIDE
duloxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL203088-002Jun 11, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Citi
Merck
Chubb
Boehringer Ingelheim
Express Scripts
Healthtrust
US Army
McKesson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot